Endocrinology Hormone Reagents Market Size, Share, Growth Trends, Industry Analysis and Forecast to 2030
Report ID: RC144842 | Report Format: PDF + Excel | Last Updated: August 28th, 2025The global endocrinology hormone reagents market size was valued at around USD 6 billion in 2024 and accounted to register a significant CAGR of over 8% during the forecast period 2025 to 2030. The increasing incidence of endocrine disease due to hormonal imbalance is a key factor to drive the market growth. Moreover, early diagnosis and screening due to increasing awareness in the public regarding health are expected to propel the market. Furthermore, the increasing establishment of diagnosis centers by the government to perform early screening of hormonal imbalances is projected to support the market growth over the forecast period.
Market Snapshot:
| Benchmark Year | 2024 | ||
| Market Size | ~ USD 6 Billion in 2024 | ||
| Market Growth (CAGR) | > 8% (2025-2030) | ||
| Largest Market Share | North America | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Agilent Technologies, Inc., Quest Diagnostics. , bioMerieux SA., Bio Rad Laboratories, Inc., and Abbott Laboratories, Inc. |
Industry Trends Shaping the Endocrinology Hormone Reagents Market
The endocrinology hormone reagents market is experiencing growth driven by rising incidences of endocrine disorders such as diabetes, thyroid dysfunction, and reproductive health issues. With increasing lifestyle-related diseases and an aging population, there is a heightened demand for accurate diagnostic tests that utilize advanced hormone reagents. Technological advancements in immunoassays, chemiluminescence assays, and automated platforms are enhancing sensitivity and specificity, fueling adoption across clinical laboratories and research institutions. Additionally, personalized medicine and precision diagnostics are reshaping the market, as clinicians require more reliable reagents to tailor therapies based on patient-specific hormonal profiles.
Another key trend is the integration of automation and digital technologies in endocrinology testing, which is improving lab efficiency and reducing turnaround times. Companies are also focusing on developing reagents compatible with high-throughput analyzers to meet the growing demand for faster diagnostics. Furthermore, regulatory approvals and quality compliance remain critical drivers, as manufacturers emphasize consistency and reliability of test results. In recent years, collaborations between diagnostic companies and research institutes have accelerated innovation, with increasing investment in biomarker discovery for early detection of endocrine disorders. These advancements collectively indicate a shift toward more advanced, accurate, and efficient hormone testing solutions in the global market.
Endocrinology Hormone Reagents Market Key Drivers:
- Increasing Prevalence of Endocrine Disorders: The rising prevalence of endocrine disorders, such as diabetes, thyroid disorders, and hormonal imbalances, drives the demand for hormone reagents used in the diagnosis and management of these conditions. Factors such as sedentary lifestyles, poor dietary habits, and aging populations contribute to the increased incidence of endocrine disorders.
- Advancements in Diagnostic Technologies: Technological advancements in diagnostic technologies have improved the detection and monitoring of endocrine disorders. Hormone reagents are essential components in various diagnostic tests, including immunoassays and molecular diagnostics, enabling accurate and efficient diagnosis. Advances in diagnostic technologies drive the demand for hormone reagents.
- Increasing Demand for Point-of-Care Testing: Point-of-care testing has gained popularity due to its convenience and quick results. Hormone reagents are used in portable diagnostic devices and test kits designed for point-of-care testing of endocrine disorders. The demand for rapid and reliable diagnostic tests drives the growth of hormone reagents in the point-of-care testing market.
- Growing Awareness and Screening Programs: Increased awareness about the importance of early detection and management of endocrine disorders has led to the implementation of screening programs. These programs aim to identify individuals at risk or in the early stages of endocrine disorders. Hormone reagents play a critical role in the screening and diagnosis of these disorders, contributing to market growth.
- Rising Geriatric Population: The aging population is more susceptible to endocrine disorders, such as diabetes and hormonal imbalances. As the global population continues to age, the demand for hormone reagents for diagnosing and managing these conditions is expected to increase. The growing geriatric population drives the growth of the endocrinology hormone reagents market.
- Increasing Adoption of Hormone Replacement Therapy: Hormone replacement therapy (HRT) is commonly used to manage hormonal imbalances in menopause and other conditions. Hormone reagents are essential in monitoring hormone levels and adjusting therapy dosages. The increasing adoption of HRT in aging populations and the growing acceptance of personalized medicine contribute to the demand for hormone reagents.
- Research and Development Initiatives: Ongoing research and development activities in the field of endocrinology drive the development of new hormone reagents. Researchers and pharmaceutical companies focus on identifying novel biomarkers and developing advanced reagents for the diagnosis and monitoring of endocrine disorders. The continuous advancements in hormone reagents fuel market growth.
- Favorable Reimbursement Policies: Favorable reimbursement policies for endocrine testing and treatments promote access to healthcare services and drive the demand for hormone reagents. Reimbursement coverage for diagnostic tests and therapies encourages healthcare providers to utilize hormone reagents, contributing to market growth.
Endocrinology Hormone Reagents Market Opportunities:
The endocrinology hormone reagents market presents significant opportunities due to the rising global burden of endocrine disorders such as diabetes, obesity, infertility, and thyroid diseases. With around 589 million people worldwide affected by diabetes in 2024 (according to the International Diabetes Federation), there is a strong need for precise hormone monitoring and diagnostic tools. This creates opportunities for companies to develop advanced reagents with higher accuracy and sensitivity, especially for insulin, cortisol, estrogen, and thyroid-related assays. Additionally, the growing demand for early detection and preventive healthcare opens avenues for reagents tailored for screening programs, particularly in emerging economies where healthcare infrastructure is rapidly expanding.
Another major opportunity lies in the integration of molecular diagnostics and personalized medicine in endocrinology. As healthcare providers move toward patient-specific treatment approaches, the demand for reagents compatible with genomics and proteomics platforms is growing. Companies investing in next-generation assays that combine hormone analysis with genetic profiling stand to gain a competitive edge. Moreover, partnerships between reagent developers, diagnostic device manufacturers, and healthcare institutions are expected to accelerate innovation. With government support for chronic disease management and rising investments in healthcare R&D, the market is well-positioned for substantial expansion through the development of specialized, cost-effective, and high-performance hormone reagents.
Market Segments Insights:
The global endocrinology hormone reagents market is fragmented by test type, end-user, and geography. On the basis of test type, the market is further segmented into TSH test, insulin test, hCG test, and others. The thyroid-stimulating hormone test dominated the market and expected to maintain its dominance over the forecast period. The segment growth is contributed to the increasing incidence of thyroid disorder globally. According to the American Thyroid Association (ATA), around 60% of individuals are suffering from thyroid disease. Furthermore, the insulin test is anticipated to register a significant growth rate over the forecast period due to the increasing prevalence of type 2 diabetes across the globe.
By end-user, the market is divided into diagnostic centers, academic research institutes, and others. The diagnostics centers segment held the largest share of the global endocrinology hormone reagents market due to the rising incidence of chronic lifestyle disorders across the globe. Moreover, the research institutes segment is projected to grow at a significant growth rate due to rising demand for biomolecules for treatments such as cancers and other chronic disorders.
Endocrinology Hormone Reagents Market Segmentation:
By Test Type:
- Thyroid Stimulating Hormone (TSH) Test
- Insulin Test
- Human Chorionic Gonadotropin (hCG) Test
- Others
By End-User:
- Diagnostic Centers
- Academic Research Institutes
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage:
Geographically, the endocrinology hormone reagents market report comprises dedicated sections centering on the regional market revenue and trends. The endocrinology hormone reagents market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. The market estimates have also been provided for the historical years along with forecasts for the period from 2025 – 2030.
Endocrinology Hormone Reagents Market Competition Assessment:
Key players operating in the global endocrinology hormone reagents market are Agilent Technologies, Inc., Quest Diagnostics. , bioMerieux SA., Bio Rad Laboratories, Inc., and Abbott Laboratories, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Agilent Technologies, Inc.
- Quest Diagnostics
- LabCrop.
- DiaSorin (American Standard Companies)
- Abbott Laboratories, Inc.
- Meridian Life Science, Inc.
- bioMerieux SA.
- Bio Rad Laboratories, Inc.
- Thermo Fisher Scientific
- Roche Diagnostics
Key Questions Answered by Endocrinology hormone reagents Market Report:
- Global endocrinology hormone reagents market forecasts from 2021-2027
- Regional endocrinology hormone reagents market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
- Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
- Endocrinology hormone reagents submarket forecasts from 2021-2027 covering the market by test type, by end-user, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
- Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2021-2027
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Endocrinology Hormone Reagents Market Portraiture
2.2. Global Endocrinology Hormone Reagents Market, by Test Type, 2020 (USD Mn)
2.3. Global Endocrinology Hormone Reagents Market, by End User, 2020 (USD Mn)
2.4. Global Endocrinology Hormone Reagents Market, by Geography, 2020 (USD Mn)
3. Global Endocrinology Hormone Reagents Market Analysis
3.1. Endocrinology Hormone Reagents Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
4. Global Endocrinology Hormone Reagents Market By Test Type, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Thyroid Stimulating Hormone (TSH) Test
4.3. Insulin Test
4.4. Human Chorionic Gonadotropin (hCG) Test
4.5. Others
5. Global Endocrinology Hormone Reagents Market By End User, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Diagnostic Centers
5.3. Academic Research Institutes
5.4. Others
6. Global Endocrinology Hormone Reagents Market, By Geography, 2018 – 2027 (USD Mn)
6.1. Introduction
6.2. North America
6.2.1. Overview
6.2.2. North America Endocrinology Hormone Reagents Market by Test Type (2018-2027 USD Mn)
6.2.3. North America Endocrinology Hormone Reagents Market by End User (2018-2027 USD Mn)
6.2.4. North America Endocrinology Hormone Reagents Market by Country (2018-2027 USD Mn)
6.2.4.1. U.S.
6.2.4.2. Canada
6.3. Europe
6.3.1. Overview
6.3.2. Europe Endocrinology Hormone Reagents Market by Test Type (2018-2027 USD Mn)
6.3.3. Europe Endocrinology Hormone Reagents Market by End User (2018-2027 USD Mn)
6.3.4. Europe Endocrinology Hormone Reagents Market by Country (2018-2027 USD Mn)
6.3.4.1. Germany
6.3.4.2. U.K.
6.3.4.3. France
6.3.4.4. Italy
6.3.4.5. Rest of Europe
6.4. Asia Pacific
6.4.1. Overview
6.4.2. Asia Pacific Endocrinology Hormone Reagents Market by Test Type (2018-2027 USD Mn)
6.4.3. Asia Pacific Endocrinology Hormone Reagents Market by End User (2018-2027 USD Mn)
6.4.4. Asia Pacific Endocrinology Hormone Reagents Market by Country (2018-2027 USD Mn)
6.4.4.1. China.
6.4.4.2. Japan
6.4.4.3. Rest of Asia Pacific
6.5. Latin America (LATAM)
6.5.1. Overview
6.5.2. Latin America Endocrinology Hormone Reagents Market by Test Type (2018-2027 USD Mn)
6.5.3. Latin America Endocrinology Hormone Reagents Market by End User (2018-2027 USD Mn)
6.5.4. Latin America Endocrinology Hormone Reagents Market by Country (2018-2027 USD Mn)
6.5.4.1. Brazil
6.5.4.2. Mexico
6.5.4.3. Rest of Latin America
6.6. Middle East and Africa
6.6.1. Overview
6.6.2. MEA Endocrinology Hormone Reagents Market by Test Type (2018-2027 USD Mn)
6.6.3. MEA Endocrinology Hormone Reagents Market by End User (2018-2027 USD Mn)
6.6.4. Middle East and Africa Endocrinology Hormone Reagents Market, by Country (2018-2027 USD Mn)
6.6.4.1. GCC
6.6.4.2. Rest of MEA
7. Company Profiles
7.1. Agilent Technologies, Inc.
7.1.1. Business Description
7.1.2. Financial Health and Budget Allocation
7.1.3. Product Positions/Portfolio
7.1.4. Recent Development
7.1.5. SWOT Analysis
7.2. Quest Diagnostics
7.2.1. Business Description
7.2.2. Financial Health and Budget Allocation
7.2.3. Product Positions/Portfolio
7.2.4. Recent Development
7.2.5. SWOT Analysis
7.3. LabCorp.
7.3.1. Business Description
7.3.2. Financial Health and Budget Allocation
7.3.3. Product Positions/Portfolio
7.3.4. Recent Development
7.3.5. SWOT Analysis
7.4. DiaSorin (American Standard Companies)
7.4.1. Business Description
7.4.2. Financial Health and Budget Allocation
7.4.3. Product Positions/Portfolio
7.4.4. Recent Development
7.4.5. SWOT Analysis
7.5. Abbott Laboratories, Inc.
7.5.1. Business Description
7.5.2. Financial Health and Budget Allocation
7.5.3. Product Positions/Portfolio
7.5.4. Recent Development
7.5.5. SWOT Analysis
7.6. Meridian Life Science, Inc.
7.6.1. Business Description
7.6.2. Financial Health and Budget Allocation
7.6.3. Product Positions/Portfolio
7.6.4. Recent Development
7.6.5. SWOT Analysis
7.7. bioMerieux SA.
7.7.1. Business Description
7.7.2. Financial Health and Budget Allocation
7.7.3. Product Positions/Portfolio
7.7.4. Recent Development
7.7.5. SWOT Analysis
7.8. Bio Rad Laboratories, Inc.
7.8.1. Business Description
7.8.2. Financial Health and Budget Allocation
7.8.3. Product Positions/Portfolio
7.8.4. Recent Development
7.8.5. SWOT Analysis
7.9. Thermo Fisher Scientific
7.9.1. Business Description
7.9.2. Financial Health and Budget Allocation
7.9.3. Product Positions/Portfolio
7.9.4. Recent Development
7.9.5. SWOT Analysis
7.10. Roche Diagnostics
7.10.1. Business Description
7.10.2. Financial Health and Budget Allocation
7.10.3. Product Positions/Portfolio
7.10.4. Recent Development
7.10.5. SWOT Analysis
To know more about the report, request a report sample
List of Tables:
TABLE 1 Market Snapshot: Global Endocrinology Hormone Reagents Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Challenges
TABLE 4 Global Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 5 Global Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 6 North America Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 7 North America Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 8 North America Endocrinology Hormone Reagents Market Value, By Country, 2018 - 2027 (US$ Mn)
TABLE 9 U.S. Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 10 U.S. Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 11 Canada Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 12 Canada Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 13 Europe Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 14 Europe Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 15 Europe Endocrinology Hormone Reagents Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 16 Germany Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 17 Germany Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 18 U.K. Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 19 U.K. Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 20 France Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 21 France Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 22 Italy Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 23 Italy Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 24 Rest of Europe Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 25 Rest of Europe Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 26 Asia Pacific Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 27 Asia Pacific Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 28 Asia Pacific Endocrinology Hormone Reagents Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 29 Japan Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 30 Japan Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 31 China Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 32 China Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 33 Rest of Asia Pacific Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 34 Rest of Asia Pacific Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 35 Latin America Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 36 Latin America Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 37 Latin America Endocrinology Hormone Reagents Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 38 Brazil Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 39 Brazil Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 40 Mexico Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 41 Mexico Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 42 Rest of Latin America Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 43 Rest of Latin America Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 44 Middle East & Africa Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 45 Middle East & Africa Endocrinology Hormone Reagents Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 46 Middle East & Africa Endocrinology Hormone Reagents Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 47 GCC Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 48 GCC Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 49 Rest of MEA Endocrinology Hormone Reagents Market Value, by Test Type, 2018 - 2027 (US$ Mn)
TABLE 50 Rest of MEA Endocrinology Hormone Reagents Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 51 Agilent Technologies, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 52 Quest Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 53 LabCorp.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 54 DiaSorin: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 55 Abbott Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 56 Meridian Life Science, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 57 bioMerieux SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 58 Bio Rad Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 59 Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 60 Roche Diagnostics., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
To know more about the report, request a report sample
List of Figures:
FIG. 1 Global Endocrinology Hormone Reagents: Market Segmentation
FIG. 2 Global Endocrinology Hormone Reagents Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Endocrinology Hormone Reagents Market, by Test Type, 2019 (US$ Mn)
FIG. 5 Global Endocrinology Hormone Reagents Market, by End-User, 2019 (US$ Mn)
FIG. 6 Global Endocrinology Hormone Reagents Market, by Geography, 2019 (US$ Mn)
FIG. 7 Global Endocrinology Hormone Reagents Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Market Positioning of Key Endocrinology Hormone Reagents Providers, 2019
FIG. 10 Global Endocrinology Hormone Reagents Market Value Share, by Test Type, 2018 & 2027 (%)
FIG. 11 Global Endocrinology Hormone Reagents Market Value for Thyroid Stimulating Hormone (TSH) Test, 2018 - 2027, (US$ Mn)
FIG. 12 Global Endocrinology Hormone Reagents Market Value for Insulin Test, 2018 - 2027, (US$ Mn)
FIG. 13 Global Endocrinology Hormone Reagents Market Value for Human Chorionic Gonadotropin (hCG) Test, 2018 - 2027, (US$ Mn)
FIG. 14 Global Endocrinology Hormone Reagents Market Value for Others, 2018 - 2027, (US$ Mn)
FIG. 15 Global Endocrinology Hormone Reagents Market Value Share, by End-User, 2018 & 2027 (Value %)
FIG. 16 Global Endocrinology Hormone Reagents Market Value for Diagnostic Centers, 2018 - 2027 (US$ Mn)
FIG. 17 Global Endocrinology Hormone Reagents Market Value for Academic Research Institutes, 2018 - 2027 (US$ Mn)
FIG. 18 Global Endocrinology Hormone Reagents Market Value for Others, 2018 - 2027 (US$ Mn)
FIG. 19 North America Endocrinology Hormone Reagents Market Value, 2018 - 2027, (US$ Mn)
FIG. 20 Europe Endocrinology Hormone Reagents Market Value, 2018 - 2027, (US$ Mn)
FIG. 21 Asia Pacific Endocrinology Hormone Reagents Market Value, 2018 - 2027, (US$ Mn)
FIG. 22 LATIN America Endocrinology Hormone Reagents Market Value, 2018 - 2027, (US$ Mn)
FIG. 23 Middle East & Africa Endocrinology Hormone Reagents Market Value, 2018 - 2027, (US$ Mn)
$ 5200/- Multi User License
We understand that every business has unique requirements. This report can be customized based on:
- Deep regional & country-level market intelligence
- Application-specific and end-use industry segmentation
- Competitive landscape & strategic benchmarking
- Go-to-market and expansion strategy insights
- Custom data cuts aligned to your business goals
- Structured Primary Research Framework
- On-Demand Industry Expert Interviews Available
- Dedicated Analyst Support
- Custom Data On Request
- Post-Purchase Strategy Consultation
- Complimentary 30-min Analyst Session
- 30% of Our Clients Are Returning Enterprise Buyers
Our Clients
